Jefferies Group LLC Coherus Bio Sciences, Inc. Transaction History

Jefferies Group LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.92 - $16.41 $539,251 - $810,358	-49,382 Closed	0 $0
Q4 2021 Sep 21, 2023	SELL	$15.81 - $18.99 $1.44 Million - $1.73 Million	-91,157 Reduced 82.66%	19,128 $305,000
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $875,905 - $1.05 Million	-55,402 Reduced 52.87%	49,382 $682,000
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $1.47 Million - $2.06 Million	-115,786 Reduced 52.49%	104,784 $1.68 Million
Q2 2021 Sep 21, 2023	BUY	$12.95 - $15.41 $1.43 Million - $1.7 Million	110,285 New	110,285 $1.53 Million
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $2.32 Million - $2.77 Million	179,479 Added 436.78%	220,570 $3.05 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $202,661 - $391,255	17,366 Added 73.2%	41,091 $666,000
Q4 2019 Feb 13, 2020	SELL	$16.33 - $21.37 $102,470 - $134,096	-6,275 Reduced 20.92%	23,725 $427,000
Q3 2019 Nov 13, 2019	BUY	$16.3 - $23.37 $163,000 - $233,700	10,000 Added 50.0%	30,000 $608,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $262,000 - $442,000	20,000 New	20,000 $442,000
Q1 2019 May 15, 2019	SELL	$8.38 - $15.5 $84,302 - $155,930	-10,060 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.65 - $16.28 $87,019 - $163,776	10,060 New	10,060 $91,000

132

77.3M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $87.1M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.